- Home
- / Nurosene Health
- / Financials
Header placeholder lorem ipsum dolor sit amet, consectetur adipiscing elit.
Nurosene Health financials data including stock price, CreditSafe score, income statement, balance sheet, and cash flow.
Stock Price
$0.4
2023-04-03
Market Capitalization
$20.1 M
2023-04-03
Revenue
$432 K
FY, 2025
CreditSafe Score
?
Score changed on Jul 23, 2026
Premium Content only available in Craft’s Intelligence Portal
View 30+ financial ratio metrics including price-to-earnings ratio, debt-to-assets ratio, gross profit margin, and more.
Financial ratio metrics help evaluate the financial strength of a company, and help raise red flags that can indicate potential risk, fulfillment challenges, or even possible bankruptcy.
Learn moreFinancial Statements
| CAD | FY, 2020 | FY, 2021 | FY, 2022 | FY, 2023 | FY, 2024 | FY, 2025 |
|---|---|---|---|---|---|---|
| Revenue | 113.0K | 89.0K | 456.0K | 432.0K | ||
| Gross profit | 113.0K | 89.0K | 456.0K | 432.0K | ||
| Gross profit margin, % | 100.0% | 100.0% | 100.0% | 100.0% | ||
| Operating expense total | 293.0K | 3.7M | 4.7M | 3.2M | 3.9M | 5.7M |
| Depreciation and amortization | 6.4M | 8.9M | ||||
| EBITDA | (293.0K) | (3.7M) | (4.6M) | (3.1M) | (3.5M) | (5.3M) |
| EBITDA margin, % | -4049.6% | -3528.1% | -761.4% | -1218.3% | ||
| EBIT | (293.0K) | (3.7M) | (10.9M) | (11.9M) | (3.3M) | (5.2M) |
| EBIT margin, % | -9678.8% | -13427.0% | -730.7% | -1208.6% | ||
| Pre tax profit | (292.0K) | (5.1M) | (13.7M) | (14.2M) | (3.3M) | (5.2M) |
| Income tax expense | (248.0K) | |||||
| Net Income | (292.0K) | (5.1M) | (13.4M) | (14.2M) | (3.3M) | (5.2M) |